AUG 04, 2015 11:22 AM PDT

Decoding Chromosome 21

WRITTEN BY: Ilene Schneider
A gene on a chromosome linked with Down syndrome also has implications for developing childhood leukemia, according to researchers at Northwestern University School of Medicine. Their work, published in the Journal of Experimental Medicine and reported in Bioscience Technology, sheds light on how the DYRK1A gene functions (http://www.biosciencetechnology.com/news/2015/08/uncovering-genetic-factors-leukemia?et_cid=4709958&et_rid=45505806&type=cta).
Northwestern University researchers pinpoint the reason children with Down syndrome are more likely to contract leukemia.
According to the American Cancer Society, children with Down syndrome have an extra (third) copy of chromosome 21 (also called trisomy). These children are 20 times more likely to develop either acute lymphocytic leukemia or acute myeloid leukemia than are other children, with an overall risk of about 2 to 3 percent. Down syndrome has also been linked with transient leukemia, a leukemia-like condition within the first month of life, which often resolves on its own without treatment (http://www.cancer.org/cancer/leukemiainchildren/detailedguide/childhood-leukemia-risk-factors).

Because that chromosome is important for research in the genetic basis of the cancer, it is a "major goal...to identify the specific gene - or genes - on chromosome 21 responsible for the increased incidence of leukemia in this population," said study senior author John Crispino, Ph.D., Robert I. Lurie, M.D., and Lora S. Lurie Professor in Medicine-Hematology/Oncology and Biochemistry and Molecular Genetics. Supported by a National Institutes of Health grant, the Samuel Waxman Cancer Research Foundation, the Leukemia and Lymphoma Society, the Rally Foundation and the Bear Necessities Foundation, Crispino's laboratory conducted a study to determine how the leukemia-promoting DYRK1A gene works in cells.

Crispino and his colleagues previously discovered that a gene on chromosome 21 called DYRK1A is linked with the development of leukemia. In the recent study they expanded on that research by evaluating the gene in depth. They specifically sought an understanding of how DYRK1A plays a part in blood cell production. The over-production of immature lymphocytes is a characteristic of acute lymphoblastic leukemia.

Crispino, along with first author Benjamin Thompson, M.D., Ph.D., a postdoctoral fellow, developed a mouse model that does not have DYRK1A in blood cells. The researchers noted that two types of white blood cells -- B and T lymphocytes -- were greatly hampered from developing without the gene. They also discovered evidence that DYRK1A is usually "responsible for regulating cell cycle progression in those lymphocytes." As they explained, "Because they have extra copies of chromosome 21, children with Down syndrome have more DYRK1A than usual."

Crispino concluded, "This finding is exciting to us because human B-cell acute lymphoblastic leukemia cases show increased levels of DYRK1A. The results suggest that DYRK1A may be a novel target for therapy in this form of leukemia."
About the Author
Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
MAR 07, 2022
Genetics & Genomics
Transcriptional Regulator BEND3 Found to Control Cell Differentiation
MAR 07, 2022
Transcriptional Regulator BEND3 Found to Control Cell Differentiation
Like embryonic stem cells, pluripotent stem cells can also specialize into any type of cell in the body by following bio ...
MAR 17, 2022
Drug Discovery & Development
CRISPR Vaccine Shows Promise in Preventing Disfiguring Skin Disease
MAR 17, 2022
CRISPR Vaccine Shows Promise in Preventing Disfiguring Skin Disease
Researchers at the Ohio State University College of Medicine have created a vaccine using CRISPR technology targeting Le ...
MAR 26, 2022
Genetics & Genomics
Tumor Microvesicles Can Spread Mutated DNA
MAR 26, 2022
Tumor Microvesicles Can Spread Mutated DNA
The growth of tumors depends in part on its microenvironment, a dynamic area surrounding the tumor, which can include no ...
MAY 24, 2022
Genetics & Genomics
The Oat Genome Reveals Why It's Good for the Gut
MAY 24, 2022
The Oat Genome Reveals Why It's Good for the Gut
You may have heard of haploid and diploid species, which carry one set of unpaired chromosomes, or two sets chromosomes, ...
MAY 24, 2022
Cell & Molecular Biology
CRISPR Cockroaches? Gene-Editing in Insects is Now Possible
MAY 24, 2022
CRISPR Cockroaches? Gene-Editing in Insects is Now Possible
In another advance for CRISPR technology, researchers have devised a way to edit genes in insects, including cockroaches ...
JUN 19, 2022
Genetics & Genomics
What are Supergenes & Why are They Hot?
JUN 19, 2022
What are Supergenes & Why are They Hot?
When parents mate and produce offspring, their genomes recombine, shuffling the genetic information within. But supergen ...
Loading Comments...